Diasorin’s LIAISON® XL analyzer has reached 7000 installations worldwide, equipping teams like yours with the power to transform patient care.
Watch the video below to see how the LIAISON® XL empowers labs to deliver faster results using fewer resources.
Unparallelled Process Management
End-to-End Automation: Free up time and resources by automating more tasks, using the LIAISON®XL as a stand-alone machine or integrated within an existing automated track.
Minimize Human Error: Ensure accuracy with complete traceability and standardized processing.
Endless Possibilities: LIAISON®XL grants greater overall testing efficiency and can also be used to consolidate specialty testing onto a single, fully-automated platform.
Minimize Human Error: Ensure accuracy with complete traceability and standardized processing.
Endless Possibilities: LIAISON®XL grants greater overall testing efficiency and can also be used to consolidate specialty testing onto a single, fully-automated platform.
Enhanced Diagnostic Competence
Streamlined Workflow: The intuitive, compact design and all-inclusive Reagent Integral format for all assays make operation a breeze, minimizing errors and maximizing efficiency.
Fast and Comprehensive Insights: Run up to 25 different tests concurrently to quickly get a complete clinical picture, enabling faster, more informed treatment decisions.
Unleash Hidden Potential: Having full access to unique strategic assays and specialty tests opens new opportunities to differentiate your lab
Fast and Comprehensive Insights: Run up to 25 different tests concurrently to quickly get a complete clinical picture, enabling faster, more informed treatment decisions.
Unleash Hidden Potential: Having full access to unique strategic assays and specialty tests opens new opportunities to differentiate your lab
LIAISON® XL pairs powerful yet simple diagnostics technology with high sensitivity and precision to deliver top performance for labs of all sizes. Its reliable speed and accuracy let you do more, even with high testing volumes.
.
Questions? Ask us how the LIAISON® XL can enhance your lab
| Our Solution | ||
| Immunodiagnostic | ||
| Molecular Diagnostic | ||
|
| Useful Links | Legal information |
| Contact us | Legal notice |
| Diasorin worldwide | Privacy policy |
| Immuno products catalog | Modern slavery statement |
| My Luminex | Accessibility |
| Service and support |
| Document Repository Diasorin Immuno and Molecular product documentation
Licensed Technologies and Luminex products
|
Follow us
|
Diasorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729 - Fiscal Code and Subscription to Vercelli Companies Register no 13144290155